These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 30116029)

  • 41. Subcortical amyloid relates to cortical morphology in cognitively normal individuals.
    Rahayel S; Bocti C; Sévigny Dupont P; Joannette M; Lavallée MM; Nikelski J; Chertkow H; Joubert S
    Eur J Nucl Med Mol Imaging; 2019 Oct; 46(11):2358-2369. PubMed ID: 31346756
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association Between Serum Triglycerides and Cerebral Amyloidosis in Cognitively Normal Elderly.
    Choi HJ; Byun MS; Yi D; Choe YM; Sohn BK; Baek HW; Lee JH; Kim HJ; Han JY; Yoon EJ; Kim YK; Woo JI; Lee DY
    Am J Geriatr Psychiatry; 2016 Aug; 24(8):604-612. PubMed ID: 27311886
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Region-Specific Association of Subjective Cognitive Decline With Tauopathy Independent of Global β-Amyloid Burden.
    Buckley RF; Hanseeuw B; Schultz AP; Vannini P; Aghjayan SL; Properzi MJ; Jackson JD; Mormino EC; Rentz DM; Sperling RA; Johnson KA; Amariglio RE
    JAMA Neurol; 2017 Dec; 74(12):1455-1463. PubMed ID: 28973551
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Apathy correlates with prefrontal amyloid β deposition in Alzheimer's disease.
    Mori T; Shimada H; Shinotoh H; Hirano S; Eguchi Y; Yamada M; Fukuhara R; Tanimukai S; Zhang MR; Kuwabara S; Ueno S; Suhara T
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):449-55. PubMed ID: 24133289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cortical thickness, brain metabolic activity, and in vivo amyloid deposition in asymptomatic, middle-aged offspring of patients with late-onset Alzheimer's disease.
    Duarte-Abritta B; Villarreal MF; Abulafia C; Loewenstein D; Curiel Cid RE; Castro MN; Surace E; Sánchez SM; Vigo DE; Vázquez S; Nemeroff CB; Sevlever G; Guinjoan SM
    J Psychiatr Res; 2018 Dec; 107():11-18. PubMed ID: 30308328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longitudinal Association of Depression Symptoms With Cognition and Cortical Amyloid Among Community-Dwelling Older Adults.
    Gatchel JR; Rabin JS; Buckley RF; Locascio JJ; Quiroz YT; Yang HS; Vannini P; Amariglio RE; Rentz DM; Properzi M; Donovan NJ; Blacker D; Johnson KA; Sperling RA; Marshall GA;
    JAMA Netw Open; 2019 Aug; 2(8):e198964. PubMed ID: 31397865
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amyloid-β, anxiety, and cognitive decline in preclinical Alzheimer disease: a multicenter, prospective cohort study.
    Pietrzak RH; Lim YY; Neumeister A; Ames D; Ellis KA; Harrington K; Lautenschlager NT; Restrepo C; Martins RN; Masters CL; Villemagne VL; Rowe CC; Maruff P;
    JAMA Psychiatry; 2015 Mar; 72(3):284-91. PubMed ID: 25629787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology.
    Okada H; Ouchi Y; Ogawa M; Futatsubashi M; Saito Y; Yoshikawa E; Terada T; Oboshi Y; Tsukada H; Ueki T; Watanabe M; Yamashita T; Magata Y
    Brain; 2013 Oct; 136(Pt 10):3004-17. PubMed ID: 23975517
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer's disease.
    Hanseeuw BJ; Lopera F; Sperling RA; Norton DJ; Guzman-Velez E; Baena A; Pardilla-Delgado E; Schultz AP; Gatchel J; Jin D; Chen K; Reiman EM; Johnson KA; Quiroz YT
    Alzheimers Res Ther; 2019 Feb; 11(1):17. PubMed ID: 30717814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Associations of thyroid hormone serum levels with in-vivo Alzheimer's disease pathologies.
    Choi HJ; Byun MS; Yi D; Sohn BK; Lee JH; Lee JY; Kim YK; Lee DY;
    Alzheimers Res Ther; 2017 Aug; 9(1):64. PubMed ID: 28818092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amyloid burden and incident depressive symptoms in preclinical Alzheimer's disease.
    Perin S; Harrington KD; Lim YY; Ellis K; Ames D; Pietrzak RH; Schembri A; Rainey-Smith S; Salvado O; Laws SM; Martins RN; Villemagne VL; Rowe CC; Masters CL; Maruff P;
    J Affect Disord; 2018 Mar; 229():269-274. PubMed ID: 29329059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG.
    Carter SF; Schöll M; Almkvist O; Wall A; Engler H; Långström B; Nordberg A
    J Nucl Med; 2012 Jan; 53(1):37-46. PubMed ID: 22213821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amyloid β deposition in subcortical stroke patients and effects of educational achievement: A pilot study.
    Yasuno F; Kajimoto K; Ihara M; Taguchi A; Yamamoto A; Fukuda T; Kazui H; Iida H; Nagatsuka K
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1651-1657. PubMed ID: 31328305
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The evaluation of brain perfusion SPECT using an easy Z-score imaging system in the mild cognitive impairment subjects with brain amyloid-β deposition.
    Takemaru M; Kimura N; Abe Y; Goto M; Matsubara E
    Clin Neurol Neurosurg; 2017 Sep; 160():111-115. PubMed ID: 28715708
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age.
    Sutphen CL; Jasielec MS; Shah AR; Macy EM; Xiong C; Vlassenko AG; Benzinger TL; Stoops EE; Vanderstichele HM; Brix B; Darby HD; Vandijck ML; Ladenson JH; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Sep; 72(9):1029-42. PubMed ID: 26147946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationships among Cortical Glutathione Levels, Brain Amyloidosis, and Memory in Healthy Older Adults Investigated In Vivo with
    Chiang GC; Mao X; Kang G; Chang E; Pandya S; Vallabhajosula S; Isaacson R; Ravdin LD; ; Shungu DC
    AJNR Am J Neuroradiol; 2017 Jun; 38(6):1130-1137. PubMed ID: 28341718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anxiety and depression among amyloid light-chain cardiac amyloidosis patients: The role of life satisfaction.
    Smorti M; Guarnieri S; Bergesio F; Perfetto F; Cappelli F
    Eur J Cardiovasc Nurs; 2016 Jun; 15(4):269-75. PubMed ID: 25601945
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Late-Life Depression and Alzheimer's Disease Pathology: An Ounce of Prevention, a Pound of Cure.
    Gatchel JR
    Am J Geriatr Psychiatry; 2021 May; 29(5):458-461. PubMed ID: 33293249
    [No Abstract]   [Full Text] [Related]  

  • 59. Loneliness as a Marker of Brain Amyloid Burden and Preclinical Alzheimer Disease.
    Rosenberg PB
    JAMA Psychiatry; 2016 Dec; 73(12):1237-1238. PubMed ID: 27806158
    [No Abstract]   [Full Text] [Related]  

  • 60. At the crossroads of preclinical AD and normal brain ageing.
    Okonkwo OC
    Lancet Neurol; 2014 Oct; 13(10):965-6. PubMed ID: 25201513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.